Ultragenyx Pharmaceutical Inc. (LON: 0LIF)

Ultragenyx Pharmaceutical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,217	3,082	2,696	4,233	6,708	1,863
Market Cap Growth	82.80%	14.35%	-36.32%	-36.89%	260.04%	7.97%
Enterprise Value	3,306	3,419	2,613	3,827	6,422	1,494
Last Close Price	34.61	37.62	38.37	61.13	60.98	28.81
PS Ratio	9.79	9.04	8.94	16.31	33.79	23.79
PB Ratio	14.46	14.26	9.21	6.21	7.93	3.77
P/TBV Ratio	37.21	60.65	21.95	7.67	9.36	5.14
EV/Sales Ratio	7.79	10.03	8.67	14.75	32.35	19.08
Debt / Equity Ratio	2.58	3.39	2.57	0.43	0.33	0.54
Asset Turnover	0.38	0.29	0.24	0.21	0.19	0.11
Inventory Turnover	19.17	22.84	34.15	35.05	34.01	39.37
Quick Ratio	2.47	2.32	3.04	4.33	6.51	7.80
Current Ratio	2.81	2.61	3.38	4.72	6.83	8.24
Return on Equity (ROE)	-289.98%	-193.23%	-110.96%	-43.72%	-20.64%	-63.79%
Return on Assets (ROA)	-24.12%	-23.43%	-26.44%	-14.54%	-14.25%	-28.58%
Return on Capital (ROIC)	-29.76%	-28.81%	-31.49%	-16.72%	-16.22%	-32.83%
Earnings Yield	-12.96%	-15.45%	-21.78%	-7.92%	-2.04%	-16.32%
FCF Yield	-9.90%	-13.22%	-15.29%	-7.18%	-1.92%	-15.00%
Buyback Yield / Dilution	-22.79%	-5.19%	-3.13%	-11.42%	-7.54%	-13.66%
Total Shareholder Return	-22.79%	-5.19%	-3.13%	-11.42%	-7.54%	-13.66%

Source: S&P Capital IQ. Standard template. Financial Sources.